ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.11
0.75%
US Tech 100
19,076.80
0.00%
S&P 500
5,599.30
0.49%
US Dollar vs CAD
1.43935
0.19%
Bitcoin
83,264.71
-0.49%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Crinetics Pharmaceuticals Inc (CRNX) Share Price

Crinetics Pharmaceuticals Inc

Crinetics Pharmaceuticals Inc (CRNX)

NASDAQ
35.40
0.00
(0.00%)
Closed March 13 3:00PM
Delayed by 15 minutes
0.00
0.00
(0.00%)
After Hours: -
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
35.40
Bid
34.71
Ask
36.09
Volume
-
0.00 Day's Range 0.00
31.84 52 Week Range 62.53
Market Cap
3.294B
Previous Close
35.40
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
960,545
Shares Outstanding
93,048,538
Dividend Yield
-
PE Ratio
-15.37
Earnings Per Share (EPS)
-2.31
Revenue
4.01M
Net Profit
-214.53M

About Crinetics Pharmaceuticals Inc

Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.crinetics.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Crinetics Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CRNX. The last closing price for Crinetics Pharmaceuticals was US$35.40. Over the last year, Crinetics Pharmaceuticals shares have traded in a share price range of US$ 31.84 to US$ 62.53.

Crinetics Pharmaceuticals currently has 93,048,538 shares outstanding. The market capitalization of Crinetics Pharmaceuticals is US$3.29 billion. Crinetics Pharmaceuticals has a price to earnings ratio (PE ratio) of -15.37.

Ask ADVFN Intelligence (AI)

Crinetics Pharmaceuticals (CRNX) Options Flow Summary

CRNX Options Flow

Overall Flow

Bullish

Net Premium

45k

Calls / Puts

100.00%

Buys / Sells

0.00%

OTM / ITM

0.00%

Sweeps Ratio

0.00%

CRNX Latest News

More News

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
March 11 2025
CRNX (0.00%)

Form 3 - Initial statement of beneficial ownership of securities
Edgar (US Regulatory)
March 05 2025
CRNX (0.00%)

Form S-8 - Securities to be offered to employees in employee benefit plans
Edgar (US Regulatory)
February 27 2025
CRNX (0.00%)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Edgar (US Regulatory)
February 27 2025
CRNX (0.00%)

Form 8-K - Current report
Edgar (US Regulatory)
February 27 2025
CRNX (0.00%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
February 24 2025
CRNX (0.00%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
February 24 2025
CRNX (0.00%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
February 24 2025
CRNX (0.00%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
11.0052.9219363279534.39535.5432.62582262034.05132594CS
4-0.12-0.33783783783835.5237.67531.8499995334.42986119CS
12-17.08-32.545731707352.4854.7831.8496054539.04256772CS
26-16.865-32.268248349852.26562.5331.8483577747.04643983CS
52-5.68-13.826679649541.0862.5331.8483118547.32986196CS
15615.8881.352459016419.5262.5315.2366694134.54257218CS
26021.66157.64192139713.7462.5310.6347303032.03109842CS

CRNX - Frequently Asked Questions (FAQ)

What is the current Crinetics Pharmaceuticals share price?
The current share price of Crinetics Pharmaceuticals is US$ 35.40
How many Crinetics Pharmaceuticals shares are in issue?
Crinetics Pharmaceuticals has 93,048,538 shares in issue
What is the market cap of Crinetics Pharmaceuticals?
The market capitalisation of Crinetics Pharmaceuticals is USD 3.29B
What is the 1 year trading range for Crinetics Pharmaceuticals share price?
Crinetics Pharmaceuticals has traded in the range of US$ 31.84 to US$ 62.53 during the past year
What is the PE ratio of Crinetics Pharmaceuticals?
The price to earnings ratio of Crinetics Pharmaceuticals is -15.37
What is the cash to sales ratio of Crinetics Pharmaceuticals?
The cash to sales ratio of Crinetics Pharmaceuticals is 822.27
What is the reporting currency for Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Crinetics Pharmaceuticals?
The latest annual turnover of Crinetics Pharmaceuticals is USD 4.01M
What is the latest annual profit for Crinetics Pharmaceuticals?
The latest annual profit of Crinetics Pharmaceuticals is USD -214.53M
What is the registered address of Crinetics Pharmaceuticals?
The registered address for Crinetics Pharmaceuticals is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Crinetics Pharmaceuticals website address?
The website address for Crinetics Pharmaceuticals is www.crinetics.com
Which industry sector does Crinetics Pharmaceuticals operate in?
Crinetics Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 75.4153
(0.00%)
0
AADIAadi Bioscience Inc
US$ 1.98
(0.00%)
0
AACGATA Creativity Global
US$ 0.9899
(0.00%)
0
AACBUArtius II Acquisition Inc
US$ 10.10
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 75.4153
(0.00%)
0
AADIAadi Bioscience Inc
US$ 1.98
(0.00%)
0
AACGATA Creativity Global
US$ 0.9899
(0.00%)
0
AACBUArtius II Acquisition Inc
US$ 10.10
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 75.4153
(0.00%)
0
AADIAadi Bioscience Inc
US$ 1.98
(0.00%)
0
AACGATA Creativity Global
US$ 0.9899
(0.00%)
0
AACBUArtius II Acquisition Inc
US$ 10.10
(0.00%)
0

CRNX Discussion

View Posts
FALCON1 FALCON1 8 months ago
https://www.zacks.com/stock/news/2300964/the-zacks-analyst-blog-highlights-danaher-morgan-stanley-pfizer-elite-pharmaceuticals-and-oil-dri

https://www.zacks.com/stock/news/2300922/zacks-initiates-coverage-of-elite-pharmaceuticals-with-outperform-recommendation
👍️0
Monksdream Monksdream 8 months ago
CRNX new 52 week high
👍️0
Monksdream Monksdream 1 year ago
CRNX new 52 week high
👍️0
Monksdream Monksdream 2 years ago
CRNX No 1 on the Barchart Top 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
👍️0

Your Recent History

NASDAQ
CRNX
Crinetics Pharmaceuticals
LSE
STPU
Am Us Curve Stp
BIT
P1P1A2
BNP Paribas Issuance
NYSE
STEM
Stem
USOTC
UEPEM
Union Electric (PK)
TG
P1I
Piaggio & C
BIT
UB0JMB
UniCredit Bank
BIT
UC4SRY
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads